Developments in vaccine policy include RFK Jr.'s shifting stance on vaccine safety during a congressional hearing and Trump's nomination of vaccine supporter Dr. Erica Schwartz as the new CDC Director. These moves signal a potential change in the political landscape surrounding public health.
A recent analysis of Alzheimer's drugs has sparked significant debate, with some experts challenging the review's conclusions regarding the clinical benefit of certain treatments. The controversy surrounds whether the analysis fairly represents recently approved medications.